Physician

Steven J Carr, MD

According to 2025 Medicare claims, Steven Carr, MD (NPI: 1790988947) practices interventional cardiology in the Cape Girardeau, MO-IL market, with the plurality of this provider's patient population coming from Cape Girardeau, MO. This provider's primary affiliated billing organization is SOUTHEAST MISSOURI HOSPITAL PHYSICIANS, LLC (NPI: 1558311522; TIN: 431912860) and primary practice location at 63703-5761. Carr is affiliated with the Mercy Health ACO, LLC (ACO ID: A2616), Caravan Health ACO 50 LLC (ACO ID: A5160), and Quality Health Partners, LLC (ACO ID: A5553), participating under the MSSP model.

Carr's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,087 traditional Medicare patients, billed 9,039 HCPCS/CPT codes, and received $261,759 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 15,168 prescription claims across 1,384 beneficiaries totaling $2,337,473 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 38 claims. Open Payments data shows 79 records totaling $1,549. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $434,431 to $2,337,473. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $11,244 to $1,272.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,344	7,651	$308,809
2016	2,485	7,938	$309,958
2017	2,749	8,710	$334,501
2018	2,722	8,362	$314,046
2019	2,510	7,656	$313,350
2020	2,386	7,605	$310,901
2021	2,356	8,287	$326,791
2022	2,511	8,619	$339,602
2023	2,200	8,828	$333,177
2024	2,087	9,039	$261,759

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	673	8,197	$434,431
2016	777	9,699	$611,280
2017	1,032	13,048	$898,497
2018	988	13,527	$926,561
2019	985	12,620	$965,529
2020	1,046	13,511	$1,249,578
2021	1,059	13,612	$1,413,130
2022	1,250	14,070	$1,709,109
2023	1,267	13,870	$2,084,541
2024	1,384	15,168	$2,337,473

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	79	$6,770
2016	N/R	119	$4,711
2017	N/R	64	$2,252
2018	N/R	65	$2,751
2019	N/R	38	$2,260
2020	N/R	18	$1,610
2021	N/R	38	$4,997
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,272	1,755	$75
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	430	440	$44
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	119	204	$11
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,127	1,408	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	690	835	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	1,034	52,018	$999,550
Xarelto	Rivaroxaban	630	29,392	$540,487
Entresto	Sacubitril/Valsartan	219	13,229	$249,041
Jardiance	Empagliflozin	133	6,420	$124,621
Repatha Sureclick	Evolocumab	159	5,746	$109,839

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	79	$1,549	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Steven J. Carr, MD?

Tedicare shows public-source Medicare data for Steven J. Carr, MD (NPI 1790988947), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steven J. Carr, MD have ACO affiliation data?

Steven J. Carr, MD is shown with ACO affiliation data for Mercy Health ACO, LLC (MSSP, ACO ID A2616), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and Quality Health Partners, LLC (MSSP, ACO ID A5553).

What billing organization is linked to Steven J. Carr, MD?

Steven J. Carr, MD is linked to SOUTHEAST MISSOURI HOSPITAL PHYSICIANS, LLC (billing NPI 1558311522) in the available physician profile data.

Does Steven J. Carr, MD have Open Payments data?

Steven J. Carr, MD has 79 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.